• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CLV
Click for more information
1.01% 49.0¢

CLOVER CORPORATION LIMITED - Announcements

Market Cap $60.11M  ! watchlist Created with Sketch. Add to my watchlist

Clover Corporation Limited is focused on technology, new product development and... Clover Corporation Limited is focused on technology, new product development and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. The Company’s microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formula, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
CLV Half Yearly Report and AccountsPRICE SENSITIVE20/03/19
CLV S&P DJI Announces March 2019 Quarterly RebalancePRICE SENSITIVE08/03/19
CLV Clarification of ex dividend datePRICE SENSITIVE24/09/18
CLV Dividend/Distribution - CLVPRICE SENSITIVE21/09/18
CLV Preliminary Final ReportPRICE SENSITIVE21/09/18
CLV Response to ASX Price QueryPRICE SENSITIVE04/05/18
CLV Half Yearly Report and AccountsPRICE SENSITIVE21/03/18
CLV Preliminary Final ReportPRICE SENSITIVE20/09/17
CLV Clover 1H17 Results - improved net profitPRICE SENSITIVE21/03/17
CLV Half Yearly Report and AccountsPRICE SENSITIVE21/03/17
CLV Preliminary Final Report-CLV.AX PRICE SENSITIVE21/09/16
CLV N3RO Clinical Research Study - Initial Results-CLV.AX PRICE SENSITIVE26/05/16
CLV Half Yearly Report and AccountsPRICE SENSITIVE23/03/16
CLV Clover enters Medical AlliancePRICE SENSITIVE12/10/15
CLV 2015 Preliminary Final ReportPRICE SENSITIVE23/09/15
CLV Market UpdatePRICE SENSITIVE31/07/15
CLV Half Yearly Report and AccountsPRICE SENSITIVE25/03/15
CLV Market UpdatePRICE SENSITIVE20/03/15
CLV Clover Appointment of Managing Director & CEOPRICE SENSITIVE11/11/14
CLV Clover achieves GRAS status for Pre-term EmulsionPRICE SENSITIVE25/09/14
CLV Preliminary Final ReportPRICE SENSITIVE24/09/14
CLV Clover Corporation - Market UpdatePRICE SENSITIVE30/06/14
CLVHalf Yearly Report and AccountsPRICE SENSITIVE26/03/14
CLV2013 AGM - Chariman's Address and MD PresentationPRICE SENSITIVE29/11/13
CLVClover Signs 5 Year Global Supply AgreementPRICE SENSITIVE21/11/13
CLVMilk Powder Contamination affects Clover SalesPRICE SENSITIVE10/10/13
CLVPreliminary Final ReportPRICE SENSITIVE18/09/13
CLVHalf Yearly Report and AccountsPRICE SENSITIVE20/03/13
CLVClover Re-signs 5 Year Global Supply AgreementPRICE SENSITIVE01/02/13
CLV2012 AGM - Chairman's Address and MD PresentationPRICE SENSITIVE30/11/12
CLVSale of Joint Venture AssetsPRICE SENSITIVE11/10/12
CLVPreliminary Final ReportPRICE SENSITIVE19/09/12
CLVHalf Yearly Report and AccountsPRICE SENSITIVE21/03/12
CLVChairman's Address to ShareholdersPRICE SENSITIVE22/11/11
CLVPreliminary Final ReportPRICE SENSITIVE21/09/11
CLVDistribution Agreement TerminatedPRICE SENSITIVE02/09/11
CLVNew Encapsulation Reseach ProgramPRICE SENSITIVE15/08/11
CLV3 Year Global Supply AgreementPRICE SENSITIVE28/07/11
CLVHalf Yearly Report and AccountsPRICE SENSITIVE23/02/11
CLV2010 Final Dividend UnconditionalPRICE SENSITIVE23/11/10
CLVPreliminary Final ReportPRICE SENSITIVE30/08/10
CLVImpairment and Divestment of Future Food IngredientsPRICE SENSITIVE09/07/10
CLVHalf Yearly Report and AccountsPRICE SENSITIVE24/02/10
CLVChairman's Address to ShareholdersPRICE SENSITIVE24/11/09
CLVTsunami in American SamoaPRICE SENSITIVE20/10/09
CLVPreliminary Final ReportPRICE SENSITIVE26/08/09
CLVAppointment of Distributor and AgentPRICE SENSITIVE16/03/09
CLVHalf Yearly Report and AccountsPRICE SENSITIVE25/02/09
CLVCLV/AoU/JAMA announcementPRICE SENSITIVE16/01/09
CLVMedia ReleasePRICE SENSITIVE28/11/08
CLV Half Yearly Report and Accounts
20/03/19PRICE SENSITIVE
CLV S&P DJI Announces March 2019 Quarterly Rebalance
08/03/19PRICE SENSITIVE
CLV Clarification of ex dividend date
24/09/18PRICE SENSITIVE
CLV Dividend/Distribution - CLV
21/09/18PRICE SENSITIVE
CLV Preliminary Final Report
21/09/18PRICE SENSITIVE
CLV Response to ASX Price Query
04/05/18PRICE SENSITIVE
CLV Half Yearly Report and Accounts
21/03/18PRICE SENSITIVE
CLV Preliminary Final Report
20/09/17PRICE SENSITIVE
CLV Clover 1H17 Results - improved net profit
21/03/17PRICE SENSITIVE
CLV Half Yearly Report and Accounts
21/03/17PRICE SENSITIVE
CLV Preliminary Final Report-CLV.AX
21/09/16PRICE SENSITIVE
CLV N3RO Clinical Research Study - Initial Results-CLV.AX
26/05/16PRICE SENSITIVE
CLV Half Yearly Report and Accounts
23/03/16PRICE SENSITIVE
CLV Clover enters Medical Alliance
12/10/15PRICE SENSITIVE
CLV 2015 Preliminary Final Report
23/09/15PRICE SENSITIVE
CLV Market Update
31/07/15PRICE SENSITIVE
CLV Half Yearly Report and Accounts
25/03/15PRICE SENSITIVE
CLV Market Update
20/03/15PRICE SENSITIVE
CLV Clover Appointment of Managing Director & CEO
11/11/14PRICE SENSITIVE
CLV Clover achieves GRAS status for Pre-term Emulsion
25/09/14PRICE SENSITIVE
CLV Preliminary Final Report
24/09/14PRICE SENSITIVE
CLV Clover Corporation - Market Update
30/06/14PRICE SENSITIVE
CLVHalf Yearly Report and Accounts
26/03/14PRICE SENSITIVE
CLV2013 AGM - Chariman's Address and MD Presentation
29/11/13PRICE SENSITIVE
CLVClover Signs 5 Year Global Supply Agreement
21/11/13PRICE SENSITIVE
CLVMilk Powder Contamination affects Clover Sales
10/10/13PRICE SENSITIVE
CLVPreliminary Final Report
18/09/13PRICE SENSITIVE
CLVHalf Yearly Report and Accounts
20/03/13PRICE SENSITIVE
CLVClover Re-signs 5 Year Global Supply Agreement
01/02/13PRICE SENSITIVE
CLV2012 AGM - Chairman's Address and MD Presentation
30/11/12PRICE SENSITIVE
CLVSale of Joint Venture Assets
11/10/12PRICE SENSITIVE
CLVPreliminary Final Report
19/09/12PRICE SENSITIVE
CLVHalf Yearly Report and Accounts
21/03/12PRICE SENSITIVE
CLVChairman's Address to Shareholders
22/11/11PRICE SENSITIVE
CLVPreliminary Final Report
21/09/11PRICE SENSITIVE
CLVDistribution Agreement Terminated
02/09/11PRICE SENSITIVE
CLVNew Encapsulation Reseach Program
15/08/11PRICE SENSITIVE
CLV3 Year Global Supply Agreement
28/07/11PRICE SENSITIVE
CLVHalf Yearly Report and Accounts
23/02/11PRICE SENSITIVE
CLV2010 Final Dividend Unconditional
23/11/10PRICE SENSITIVE
CLVPreliminary Final Report
30/08/10PRICE SENSITIVE
CLVImpairment and Divestment of Future Food Ingredients
09/07/10PRICE SENSITIVE
CLVHalf Yearly Report and Accounts
24/02/10PRICE SENSITIVE
CLVChairman's Address to Shareholders
24/11/09PRICE SENSITIVE
CLVTsunami in American Samoa
20/10/09PRICE SENSITIVE
CLVPreliminary Final Report
26/08/09PRICE SENSITIVE
CLVAppointment of Distributor and Agent
16/03/09PRICE SENSITIVE
CLVHalf Yearly Report and Accounts
25/02/09PRICE SENSITIVE
CLVCLV/AoU/JAMA announcement
16/01/09PRICE SENSITIVE
CLVMedia Release
28/11/08PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
49.0¢ 		Change
-0.005(1.01%) 		Mkt cap ! $60.11M
Open High Low Value Volume
49.0¢ 49.5¢ 49.0¢ $8.983K 18.23K

Buyers (Bids)

No. Vol. Price($)
2 32789 49.0¢
 

Sellers (Offers)

Price($) Vol. No.
50.0¢ 44797 1
View Market Depth
Last trade - 15.45pm 15/11/2024 (20 minute delay) ?
Last
49.0¢ 		  Change
-0.005 ( 1.01 %)
Open High Low Volume
49.0¢ 49.0¢ 49.0¢ 768
Last updated 12.09pm 15/11/2024 ?
CLV (ASX) Chart

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play Empire Energy (ASX:EEG) has confirmed the NT government has delivered environmental approvals for Carpentaria.
Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks Copper prices slump; Trump Wall Street rally fades; US health stocks dip on RFK appointment – and much more.
Banshee's historic trenches prove rich in antimony and gold for GDM Great Divide Mining Ltd has found high-grade antimony and gold through geochemical sampling at its Banshee prospect in Queensland
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.